C
Carlsmed
Carlsmed is personalized surgical implants for patients with debilitating spine deformities
About Carlsmed
Carlsmed operates in the medical technology sector, focusing on personalized spine surgery solutions. The company leverages patient data and advanced digital technologies to create customized surgical plans and 3D-printed spine fusion devices, known as aprevo implants. These implants are tailored to each patient's unique anatomical needs, ensuring optimal surgical outcomes. Carlsmed serves healthcare professionals, particularly spine surgeons, and their patients who require spine fusion surgeries. The business model revolves around the integration of patient imaging data, surgeon preferences, and digital design to produce bespoke surgical solutions. Revenue is generated through the sale of these personalized implants and associated surgical planning services. By providing highly customized medical devices, Carlsmed aims to improve surgical precision and patient recovery times.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2018
- Headquarters
- Carlsbad, United States
- Listing
- IPO 2025
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
The Cove Fund- WHWavemaker Three-Sixty Health
Series A3 investors entered at this stage
U.S. Venture Partners
The Vertical Group
B Capital
Series B and later1 investor entered at this stage
Customers Bank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Carlsmed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Carlsmed on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.